Wuxi Biologics (Cayman) Inc. (1FW2)
Market Closed
3 Jun, 20:00
XFRA 
€
3. 5800
-0.3
-7.73%
€
14.96B Market Cap
- P/E Ratio
- Div Yield
500 Volume
- Eps
€ 3.88
Previous Close Want to track 1FW2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Wuxi Biologics (Cayman) Inc. (1FW2) Statistics
Valuation metrics
Market Cap 14.96B
Enterprise value 1.03B
Trailing P/E (ttm) 24.13
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.69
Price/Book (mrq) 2.51
Enterprise Value/Revenue 0.37
Enterprise Value/EBITDA 1.02
Overview
Shares outstanding 4.13B
Float 3.74B
Shares short -
% Held by insiders 0.1%
% Held by institutions 0.36%
Average volume (10 days) 965
Average volume (90 days) 1.2K
Price summary
52-Week low 2.63
52-Week high 4.68
Beta 0.58
50-Day moving average 3.72
200-Day moving average 3.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 16 Nov 2020
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.23%
Operating margin 0.33%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.12%
Income Statement
Revenue (ttm) 2.76B
Revenue per share (ttm) 5.41
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 1.27B
EBITDA 8.49B
Net income to common (ttm) 620.95M
Diluted EPS (ttm) 0.15
Quarterly earnings growth (yoy) 0.38%
Balance Sheet
Total cash (mrq) 1.99B
Total cash per share (mrq) 3.81
Total debt (mrq) 392.7M
Total Debt/Equity (mrq) 5.85
Current ratio (mrq) 3.39%
Book value per share (mrq) 1.44
Cash Flow
Cash flow statement 802.19M
Levered free cash flow (LFCF) 541.98M
